clinical 1,441 words KG: PD 2026-03-28
kind:clinical-trialsection:clinical-trialsstate:published
Contents

Retigabine PD Trial

Knowledge Graph

Related Hypotheses (16)

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Microbial Inflammasome Priming Prevention
Score: 0.58
PARP1 Inhibition Therapy
Score: 0.58
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56

Related Experiments (18)

Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85

See Also (11)

LRRK2 G2019S Transgenic Mouse Model
model · KG edge: causes
Age-Sensitive Cortical Vulnerability in Parkinson's Dis
mechanism · KG edge: associated_with
MCL1 Gene - Myeloid Cell Leukemia 1
gene · KG edge: implicated_in
IDH1 Gene - Isocitrate Dehydrogenase 1
gene · KG edge: implicated_in
eef1a1
gene · KG edge: implicated_in

Knowledge Graph (12 edges)

PD causes NEURODEGENERATION
PD causes DOPAMINERGIC_NEURONS
PD causes neurodegeneration
PD contributes_to synucleinopathies
PD associated_with DEPRESSION
PD associated_with T2DM
NEUROINFLAMMATION contributes_to PD
NEUROTROPHINS treats PD
AGE associated_with PD
SNCA causes PD